The DTM5 is a concentrated investment strategy focused on early-stage publicly traded and private ventures across sectors such as Finance, Technology and Pharma. Targeting a maximum of five investments at a time, the objective of the DTM5 is exceptionally high growth over a mid/long-term time frame (5+ years).

The DTM5 Investment Criteria

The DTM5 seeks to make investments that have:

Merit, Asymmetry, and a Catalyst — at the right Time and Price

Each criterion serves a distinct purpose.

Merit

Merit is the DTM5 word for credibility.

It reflects whether the underlying business, asset, or opportunity is real, viable, and defensible. Merit is assessed through a combination of factors, including:

• Balance sheet health
• Capital structure
• Cash management and runway
• Management competence and alignment
• Strategic clarity and communication

Merit does not imply certainty — but it reduces the probability of structural failure.

Asymmetry

Asymmetry is the DTM5 word for “a good bet.”

An investment is asymmetric when the potential upside meaningfully outweighs the plausible downside, even after accounting for dilution, execution risk, and uncertainty.

Catalyst

Catalyst represents the mechanism through which uncertainty is resolved and value can become recognized — an event, decision, development, or strategic action that changes how the opportunity is understood or valued.

Catalysts may include:

• Regulatory or clinical milestones / clarity
• Strategic alternatives or M&A logic
• Capital structure pressure and resolution — cash runway, debt, dilution
• Insider or board-driven action
• Structural, operational, or solvency clarity

A catalyst does not need to be date-certain — but it must be credible.

Without a catalyst, even high-merit, highly asymmetric opportunities can remain dormant indefinitely.

Time

Time reflects the expected duration between investment and value realization.

Shorter durations are generally preferred, but only when they do not compromise asymmetry. Time is treated as a 1) a cost and 2) An opportunity. Entering positions opportunistically and allowing uncertainty to resolve can make time itself a form of arbitrage.

Price

Price is the valuation at which the investment is obtained.

DTM5 seeks situations where price reflects:

• Lack of visibility
• Uncertainty or confusion
• Temporary distress priced as permanent impairment
• Narrative or structural dislocation

Price is evaluated probabilistically, not absolutely — relative to outcomes, downside scenarios, and catalysts.

The DTM5 Edge

Any edge I earn comes from the willingness to investigate uncertainty, connect disparate information, deep dive on subject matter, understand incentives and then make probabilistic judgments at an opportune time.

Edge is not a separate investment criterion. It is the logical result of successful utilization of the 5 DTM criteria: Merit, Asymmetry, Catalyst, Time and Price

Capital Allocation & Management

Capital within the DTM5 is managed using the following principles:

High Concentration

• Focus on earlier-stage micro, and small-cap, early stage, pre revenue, emerging sector opportunities
• Maintain up to five core positions, supported by bench players
• Concentration is intentional and conviction-based

Smart Management

• Long-term commitment to winners
• Active resistance to the Disposition Effect
• Trading, profit-taking, and de-risking when valuation or conditions justify it
• Valuation-based opportunism
• Selective use of technical analysis
• Risk and position-size discipline

Supported by tools such as the DTM5 Position Size Evaluator.

Opportunity Flow

• Maintain a bench of opportunities under continuous observation
• Capital is allocated opportunistically, not reactively
• Patience is a feature, and time is treated as both a cost and an arbitrage tool.

Summary

The DTM5 is not a diversification strategy. It is a decision framework designed to identify, size, and manage high-asymmetry investments where the strategy believes it has an edge and where value realization is probable.